Novo Nordisk in the news
ShareCopied to clipboardAnalyze the latest Novo Nordisk news, with a current neutral sentiment polarity (0.27) or the entire set.
Latest news
Here are the latest news on this scope:
Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs
Eli Lilly's Zepbound beat Novo Nordisk's Wegovy in a big weight loss drug study
Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Stocks making the biggest moves premarket: Disney, Super Micro, Novo Nordisk, Uber and more
Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up
FTSE's winning streak on par with best ever run in 2017; Novo Nordisk rises 2%
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
Novo Nordisk to continue largest insulin brand Mixtard supply in vials amid penfill device phase-out
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time